In order to examine the suitability of the chronic loss of FAAH activity as a possible therapeutic approach, we examined whether the complete genetic knockout (KO) of FAAH would protect PS19 mice from progressive hyperarousal, neuroinflammation, and cognitive decline. The gene discussed is FAAH; the disease is Mental deterioration.